Tsuboi A, Matsui M, Hayata I, Tsuchiya T
In Vitro. 1980; 16(7):600-8.
PMID: 7409830
DOI: 10.1007/BF02618385.
Dalianis T, Ahrlund-Richter L, Merino F, Klein E, Klein G
Immunogenetics. 1981; 12(3-4):371-80.
PMID: 7203561
DOI: 10.1007/BF01561677.
Bestwick R, Machida C, Polonoff E, Kabat D
Mol Cell Biol. 1984; 4(5):908-14.
PMID: 6727872
PMC: 368838.
DOI: 10.1128/mcb.4.5.908-914.1984.
Frost P, Kerbel R
Cancer Metastasis Rev. 1983; 2(3):239-56.
PMID: 6231096
DOI: 10.1007/BF00048480.
Miller F
Cancer Metastasis Rev. 1982; 1(4):319-34.
PMID: 6192904
DOI: 10.1007/BF00124215.
Antigenic specificities on murine sarcoma cells. Reciprocal relationship between normal transplantation antigens (H-2) and tumor-specific immunogenicity.
Haywood G, McKHANN C
J Exp Med. 1971; 133(6):1171-87.
PMID: 5576331
PMC: 2138927.
DOI: 10.1084/jem.133.6.1171.
Detection of cell surface antigens on monolayer cells. I. The application of immune adherence on a micro scale.
Tachibana T, Klein E
Immunology. 1970; 19(5):771-82.
PMID: 5530203
PMC: 1455646.
Immunological studies on Burkitt's lymphoma.
Klein G
Postgrad Med J. 1971; 47(545):141-55.
PMID: 4932902
PMC: 2466873.
DOI: 10.1136/pgmj.47.545.141.
Demonstration of alloantibodies to HL-A antigens by immunofluorescence.
Ablin R
Urol Res. 1973; 1(4):157-60.
PMID: 4596729
DOI: 10.1007/BF00256616.
Tumour-bound immunoglobulins. The in vitro fixation of radioiodine-labelled anti-immunoglobulin reagents by tumour cells.
Witz I, Kinamon S, Ran M, Klein G
Clin Exp Immunol. 1974; 16(3):321-33.
PMID: 4549685
PMC: 1553950.
Relative importance of viral and neoantigens in cytotoxic reaction against murine leukaemia cells.
Cohen M, Sibal L, Fink M
Immunology. 1974; 26(1):37-48.
PMID: 4367312
PMC: 1423104.
Accumulation of natural killer and cytotoxic T large granular lymphocytes in the liver during virus infection.
McIntyre K, Welsh R
J Exp Med. 1986; 164(5):1667-81.
PMID: 3490535
PMC: 2188440.
DOI: 10.1084/jem.164.5.1667.
Humoral immunostimulation. V. Selection of variant cell lines.
Shearer W, Parker C
J Exp Med. 1975; 142(5):1133-49.
PMID: 1194850
PMC: 2189957.
DOI: 10.1084/jem.142.5.1133.
In vitro derived mouse A9 cell clones differing in malignancy: analysis by somatic cell hybridization with YACIR lymphoma cell clones.
Clements G, Fenyo E, Klein G
Proc Natl Acad Sci U S A. 1976; 73(6):2004-7.
PMID: 1064870
PMC: 430436.
DOI: 10.1073/pnas.73.6.2004.
Target-effector interaction in the human and murine natural killer system: specificity and xenogeneic reactivity of the solubilized natural killer-target structure complex and its loss in a somatic cell hybrid.
Roder J, Ahrlund-Richter L, Jondal M
J Exp Med. 1979; 150(3):471-81.
PMID: 479761
PMC: 2185657.
DOI: 10.1084/jem.150.3.471.
The tumor dormant state. Comparison of L5178Y cells used to establish dormancy with those that emerge after its termination.
Weinhold K, Miller D, Wheelock E
J Exp Med. 1979; 149(3):745-57.
PMID: 429962
PMC: 2184829.
DOI: 10.1084/jem.149.3.745.
Development of tumor cell resistance to syngeneic cell-mediated cytotoxicity during growth of ascitic mastocytoma P815Y.
Biddison W, Palmer J
Proc Natl Acad Sci U S A. 1977; 74(1):329-33.
PMID: 402006
PMC: 393253.
DOI: 10.1073/pnas.74.1.329.
The natural history of antitumour immunity in human breast cancer assayed by tube leucocyte adherence inhibition.
Lopez M, OConnor R, Macfarlane J, Thomson D
Br J Cancer. 1978; 38(6):660-73.
PMID: 369585
PMC: 2009831.
DOI: 10.1038/bjc.1978.271.
The tumor dormant state. Quantitation of L5178Y cells and host immune responses during the establishment and course of dormancy in syngeneic DBA/2 mice.
Weinhold K, Goldstein L, Wheelock E
J Exp Med. 1979; 149(3):732-44.
PMID: 311815
PMC: 2184833.
DOI: 10.1084/jem.149.3.732.
